Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application - Wikidata - thesis-toulmin - TriplyDB

Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application

Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application

http://www.wikidata.org/entity/Q30444715

about

Tumor-vascular interactions and tumor dormancy Metastasis suppressor genes at the interface between the environment and tumor cell growth The relationship of palliative transurethral resection of the prostate with disease progression in patients with prostate cancer.Sponge non-metastatic Group I Nme gene/protein - structure and function is conserved from sponges to humans Learning therapeutic lessons from metastasis suppressor proteins.Disrupting ovarian cancer metastatic colonization: insights from metastasis suppressor studies.Metastasis: a therapeutic target for cancer.Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expression Identification of essential sequences for cellular localization in BRMS1 metastasis suppressor.Selection in spatial stochastic models of cancer: migration as a key modulator of fitness Meta-analysis of multiple microarray datasets reveals a common gene signature of metastasis in solid tumors.A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12.Metastasis suppressor NM23-H1 promotes repair of UV-induced DNA damage and suppresses UV-induced melanomagenesis.ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer.KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model.Non-metastatic 2 (NME2)-mediated suppression of lung cancer metastasis involves transcriptional regulation of key cell adhesion factor vinculin The α₂β₁ integrin is a metastasis suppressor in mouse models and human cancer.KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.Functional modulation of the metastatic suppressor Nm23-H1 by oncogenic viruses Nm23-h1 binds to gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis Emerging Roles for SSeCKS/Gravin/AKAP12 in the Control of Cell Proliferation, Cancer Malignancy, and Barriergenesis.Peroxiredoxin 6 interferes with TRAIL-induced death-inducing signaling complex formation by binding to death effector domain caspase.Metastasis suppressors and their roles in breast carcinoma.TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression Metastasis: recent discoveries and novel treatment strategies.The role of metastasis suppressor genes in metastatic dormancy.Altered gene and protein expression by Nm23-H1 in metastasis suppression.BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process.Tumor dormancy and the role of metastasis suppressor genes in regulating ectopic growth.Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.Models, mechanisms and clinical evidence for cancer dormancy.The role and potential mechanisms of LncRNA-TATDN1 on metastasis and invasion of non-small cell lung cancer.Metastasis suppressor function of tumor necrosis factor-related apoptosis-inducing ligand-R in mice: implications for TRAIL-based therapy in humans?Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model.Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol.Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12 The microRNA network and tumor metastasis.RCAN1-4 is a thyroid cancer growth and metastasis suppressor.

P2860

Q28295975-53E51EEC-2AE8-4E91-AB9A-279A729953E0 Q28394526-995E2F80-17A2-48F3-AB5C-756F5F7922D8 Q30375537-280D64C4-56F8-4618-BAAF-9A35F642064A Q30401367-0891233A-5BC5-4404-8399-1AE395FD6D65 Q30435922-2AE982F7-1C79-4699-9282-672A26A8D5E4 Q30436739-2547B8B2-4955-4065-9D4F-2B9B313DA7AA Q30439221-4C28769D-9130-47EE-852F-4BC88878C307 Q33267205-F693B64D-D372-4778-B0FE-3F88EED531C4 Q33489632-E6285A46-36F5-40BA-B8D0-8F83FF39CD4D Q33866458-72E2243B-4FC1-47DF-A358-D676482FEC4C Q33953926-6A179A9A-C819-491A-B380-0A69ADF81B16 Q33991455-4F1EEB0F-8DFC-4330-88DA-09F4E1401679 Q34073668-16A1AB22-867C-4B3D-86AE-6F4B9C1C8AD5 Q34090944-274777B5-F1DB-4AF0-9344-F28BB840B042 Q34286070-1D3B3A70-6F10-4094-9F15-37B785A4E8E3 Q34313101-A8847C13-7866-437E-B787-5364AFE81046 Q34428911-EF66D94F-0814-41E3-8C2D-FB56222AB74F Q34791651-FD83BB49-F887-4B96-A3A4-E414F90547DD Q34901718-318A4F26-6DDD-4CE2-BDD3-E463E50305BC Q34934116-8660B02E-E5E4-4179-92B8-361F4FBDC1E6 Q34972774-59FA3AA0-13EA-4CAF-BEB9-401F2837A0E5 Q35092846-406DFB8E-F56E-4F91-8CCA-3D141440D6B0 Q35981102-98450EF9-B1FC-4C30-95CD-6AC02BC9B4FD Q36249542-344D4B8F-F59A-49B9-9301-78D214CB3825 Q36357596-992A7F95-5BA7-4F90-924D-9A9E853D07D3 Q36407507-BCD7DDDF-FBCB-400E-AA69-827E7C91EC9B Q36407511-A1409598-D7C3-4CA6-A142-9643077F6A3A Q36429964-26C6E95F-B601-4F3C-B971-AAA860BD2B7C Q36445269-1A60F303-6DC1-4FB1-B07E-C277CAC3681E Q36482228-D92DDD3B-A266-4B7E-8632-A42BCECC20B7 Q36616513-C647534C-7A69-4B1F-A345-F4C0BA18A39C Q36727390-661DA76C-24AF-4210-9880-396109F9D5B7 Q36844303-C240D53B-DE83-4B56-A60A-3F4619021D01 Q37109714-108D1BB8-AA1B-4381-8A0D-75209156797A Q37234170-AF1DA1A4-16BB-4B96-BB20-C1A017F0251D Q37368130-93686873-3A94-474B-9E6E-A97C60B39C04 Q37424389-B3F24384-6DA8-4A77-BE64-9D338FC4995D Q37537319-E9D5002B-6843-4EC6-A034-451F616ED2DD Q37638140-2BD0EE5C-4209-42A7-AB40-CC0FD3038038 Q37677411-D0EA19DE-C5CF-497A-830A-9FC1D5DED3DF

P2860

Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application

http://www.wikidata.org/entity/Q30444715

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application

@ast

Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application

@en

type

label

Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application

@ast

Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application

@en

prefLabel

Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application

@ast

Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application

@en

P1433

Q30444715-E20FF215-B877-4B06-B8CC-B49EC66C2A5B

P1476

Q30444715-8BD8F723-092D-4CF0-B756-CA4CD5B49573

P2093

Q30444715-45176AFC-C200-4A21-85AE-F90F379B0E65

Q30444715-617FDED3-6ABF-4424-84C9-217BBE45B439

Q30444715-9EC22B6D-DE82-4E60-9025-C05E2F112CEE

Q30444715-E24EAEC7-AB57-4BED-B428-A6AA6E11F28E

P2860

Q30444715-05BCCE51-ADE1-482C-8C5C-635EA08B5B72

Q30444715-06C113DE-017E-492E-B1D5-7132B24739A7

Q30444715-0AB0001E-7B65-42D1-AD9A-ED1CD7CE9C8C

Q30444715-0CC5BF9E-FD20-4992-A4BC-B3F6E5130F3F

Q30444715-0CFEB440-3E7A-46CE-9F36-4A9ED52A3CF7

Q30444715-1839DD45-6905-42A2-A64A-F9DABA445390

Q30444715-19C62124-54C4-4FAE-BD98-F9E671E303DE

Q30444715-1CC6CDDE-D20B-4EDF-A27D-157FF48EECBB

Q30444715-1D8BF83A-2501-4481-887A-A506F2B7D4EE

Q30444715-265DA209-94F9-4FB5-A272-7BEA3A63ABBB

P304

Q30444715-CD43EA4C-C8B5-4150-B9B2-0F3249A41594

P31

Q30444715-0BCEE9FB-3BB2-48A6-B151-1F0FD0EB5CD7

P356

Q30444715-4ADD2DAE-8C34-468D-9B32-AD4D7CB2E1B1

P407

Q30444715-800D4C00-7099-406B-B5D9-B7E09AF57100

P433

Q30444715-530EFC85-0D28-49E2-8B65-710127ECA1CB

P478

Q30444715-B9D5CFD3-94FD-49E5-974C-CB6E0A98B627

P577

Q30444715-0F8444D3-C299-4769-983E-E87165FCA03B

P698

Q30444715-803044F9-27A2-45BC-90EA-D0621D5DD632

P932

Q30444715-EC510EF1-1691-4AEA-BEEE-C952D55DF94B

P356

1078-0432.CCR-06-1014

P1433

Clinical Cancer Research

P1476

Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application

@en

P2093

Carrie W Rinker-Schaeffer

http://www.w3.org/2001/XMLSchema#string

Dan Theodorescu

http://www.w3.org/2001/XMLSchema#string

Danny R Welch

http://www.w3.org/2001/XMLSchema#string

James P O'Keefe

http://www.w3.org/2001/XMLSchema#string

P2860

KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2

RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis.

Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein

Role of endothelin-1 in lung disease

Microarrays bring new insights into understanding of breast cancer metastasis to bone

Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP

Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP

The endothelin axis: emerging role in cancer

Multifunctional strands in tight junctions

RhoGDI2 is an invasion and metastasis suppressor gene in human cancer

P304

3882-3889

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-06-1014

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16818682

http://www.w3.org/2001/XMLSchema#string

P932

1525213

http://www.w3.org/2001/XMLSchema#string